Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
2.7500
-0.0100
(-0.36%)
At close: February 26 at 2:52:16 PM EST
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 16.02M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| Adams (William James) Senior Officer of Issuer | Acquisition or disposition under a prospectus at price 1.74 per share. | Indirect | 76,505 | Mar 28, 2024 |
| Ives (Glenn Antony) Director of Issuer | Acquisition or disposition under a prospectus at price 1.74 per share. | Indirect | 14,775 | Mar 28, 2024 |
| Kaye (Randall E) Director of Issuer | Acquisition or disposition under a prospectus at price 1.74 per share. | Direct | 17,360 | Mar 28, 2024 |
| Kelly (Michael) Director of Issuer | Acquisition or disposition under a prospectus at price 1.74 per share. | Direct | 249,909 | Mar 28, 2024 |
| Mckerracher (Krista L) Director of Issuer | Acquisition or disposition under a prospectus at price 1.74 per share. | Direct | 9,995 | Mar 28, 2024 |
| PFP Biosciences Holdings LLC 10% Security Holder of Issuer | Acquisition or disposition under a prospectus at price 1.74 per share. | Indirect | 4,998,202 | Mar 28, 2024 |
| Punnett, Harold 10% Security Holder of Issuer | Acquisition or disposition under a prospectus at price 1.74 per share. | Direct | 44,323 | Mar 28, 2024 |
| Radvak (William Joseph) Director of Issuer | Acquisition or disposition carried out privately at price 1.74 per share. | Direct | 34,720 | Mar 28, 2024 |
| Ruffolo (John) Director of Issuer | Acquisition or disposition under a prospectus at price 1.74 per share. | Indirect | 73,872 | Mar 28, 2024 |
| Radvak (William Joseph) Director of Issuer | Exercise of options at price 0.74 per share. | Direct | 74,200 | Mar 13, 2024 |
| Bayley (Brian Eric) Director of Issuer | Exercise of options at price 0.74 per share. | Direct | 74,100 | Mar 12, 2024 |
| Bayley (Brian Eric) Director of Issuer | Acquisition or disposition carried out privately at price 2.22 per share. | Direct | 333,750 | Mar 11, 2024 |
Related Tickers
AVTE Aerovate Therapeutics, Inc.
2.4300
+0.83%
MSCL.TO Satellos Bioscience Inc.
0.8300
+3.75%
EPRX Eupraxia Pharmaceuticals Inc.
4.2900
+4.63%
NRXBF NUREXONE BIOLOGIC INC
0.4200
+6.06%
NBIO Nascent Biotech, Inc.
0.0075
0.00%
NRXS NeurAxis, Inc.
2.1400
-0.93%
EPRX.TO Eupraxia Pharmaceuticals Inc.
6.01
+1.86%
MSCLF Satellos Bioscience Inc.
0.5840
0.00%
GSD.V Devonian Health Group Inc.
0.2200
0.00%
SVA.TO Sernova Biotherapeutics Inc
0.1950
-2.50%